Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Dr. Jun Tian, Executive Director and Head of Upstream Process Development at WuXi Biologics Full title: Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Systems and Stringent Process and Raw Material Controls S... 1 month ago | 43 mins Trends and Future of Pharmaceutical Continuous Manufacturing Lawrence De Belder, at Pharmatech Associates, Inc. and Jan Vogeleer at Fette Compacting In this webinar, Lawrence De Belder will give an overview of the history, present, and expected future of continuous manufacturing for drug product, d... April 27, 2023 2:00pm Novel Technologies That Aid the Detection and Differentiation of Proteinaceous.. Danny Chou, President and Founder at Compassion BioSolution, LLC Full Title: Novel Technologies That Aid the Detection and Differentiation of Proteinaceous Impurities in Biologic Drug Substances and Drug Product Pr... 2 years ago | 87 mins In-line monitoring of surfactant clearance... Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur Full Title: In-line monitoring of surfactant clearance in viral vaccine downstream processing The focus of this study is to examine the suitability o... 1 year ago | 43 mins An impurity detected in a stability study... Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe Full Title: An impurity detected in a stability study: Did we miss anything in our E&L risk assessment? Extractable and leachable (E&L) testing are r... 1 year ago | 90 mins Digitally Transforming Pharmaceutical Process Development and Manufacturing Moiz Diwan, Ph.D. Process Research and Development, AbbVie Inc., North Chicago, IL Digitally Transforming Pharmaceutical Process Development and Manufacturing: Enabling Technologies for a Sustainable Future The focus on accelerated ... 6 months ago | 42 mins Next Generation Bioprocess Facility Design - A Case Study From Samsung Biologics Ken Green, Ph.D, Science and Technology at Samsung Biologics. John Bonham-Carter. Product Line Leader, Repligen A case study be presented describing initiatives and bioprocessing approaches to maximize capacity utilization within a new large scale (12x 15kL) dru... 2 years ago | 97 mins Operational Excellence in Process Development in Drug Substance Production Presented by Ken Green, Ph.D, Head of MSAT at Samsung Biologics and Klaus Mauch, CEO at Insilico Biotechnology AG This presentation will highlight Samsung Biologics (SBL) approach to align process development activities with technology transfer and cGMP manufactur... 2 years ago | 107 mins De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing... Prateek Gupta, PhD Senior Vice President, Process Development & MSAT at Stelis Biopharma Ltd. Full Title: De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing for Gene Therapy Applications The rush to develop an affordable and... September 13, 2023 2:00pm A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins
